Abstract:Breast cancer is a common malignancy with the highest mortality rate among women worldwide. Its incidence is on the rise year after year, accounting for more than one-tenth of new cancers worldwide. Increasing evidence suggests that forkhead box (FOX) transcription factors play an important role in the occurrence and development of breast cancer. However, little is known about the relationship between the expression, prognostic value, function, and immune infiltration of FOX transcription factors in tumor microenvironment. We used bioinformatics to investigate expression and function of FOX factor in breast cancer. Our results revealed the expression levels of FOXA1 and FOXM1 were significantly higher in breast cancer tissues than in normal tissues. The high expression of mRNA in FOXA1 (P < .05), FOXM1 (P < .01), and FOXP1 (P < .05) groups was related to tumor stage. Survival analysis results showed that increased FOXP1 mRNA levels were significantly associated with overall survival (OS), recurrence-free survival (RFS), and distant metastasis-free survival (DMFS) in all patients with breast cancer (P < .05). Patients with the FOXA1 high-expression group had better RFS and DMFS than the low-expression group (P < .05), while patients with FOXM1 high-expression group had worse RFS, OS, and DMFS than the low-expression group (P < .05). Meanwhile, mutation analysis showed that genetic alterations in FOX transcription factors were significantly associated with shorter OS and progression-free survival (P < .05), but not with disease-free survival (P = .710) in patients with breast cancer. FOXP1, FOXA1, and FOXM1 may be used as potential biomarkers to predict the prognosis of patients with breast cancer. Functional enrichment indicated that FOX was mainly involved in cell division, cell senescence, cell cycle, and prolactin signaling pathway. In patients with breast cancer, FOXC2 expression was negatively correlated with the infiltration of B cells and positively correlated with the infiltration of neutrophils and dendritic cells. However, FOXM1 was negatively correlated with the infiltration of CD8 + T cells and macrophages and positively correlated with the infiltration of neutrophils and dendritic cells. These findings provided novel insights into the screening of prognostic biomarkers of the FOX family in breast cancer and laid a foundation for further research on the immune infiltration of the FOX transcription factor family members in tumors.

The Transcription Factor FOXA1 Induces Epithelial Ovarian Cancer Tumorigenesis and Progression

FOXN Transcription Factors: Regulation and Significant Role in Cancer

FOXN Transcription Factors: Regulation and Significant Role in Cancer.

Overexpression of FOXM1 Predicts Poor Prognosis and Promotes Cancer Cell Proliferation, Migration and Invasion in Epithelial Ovarian Cancer.

Systematic Pan-Cancer Analysis and Experimental Verification Identify FOXA1 as an Immunological and Prognostic Biomarker in Epithelial Ovarian Cancer

FOXO1 overexpression is correlated with poor prognosis in epithelial ovarian cancer.

FOXO1 is a Tumor Suppressor in Cervical Cancer

The role of transcription factor FOXA1/C2/M1/O3/P1/Q1 in breast cancer

The Role of FOXA1 in Human Normal Development and Its Functions in Sex Hormone-Related Cancers

FoxO1 Promotes Ovarian Cancer by Increasing Transcription and METTL14-mediated M6a Modification of SMC4

Cyclin F and KIF20A, FOXM1 target genes, increase proliferation and invasion of ovarian cancer cells

FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer

Increased FOXA1 Levels Induce Apoptosis and Inhibit Proliferation in FOXA1-low Expressing Basal Breast Cancer Cells.

FOXD 1 is Targeted by Mir-30 A-5 P and Mir-200 A-5 P and Suppresses the Proliferation of Human Ovarian Carcinoma Cells by Promoting P 21 Expression in a P 53-Independent Manner

FOXM1 Promotes Reprogramming of Glucose Metabolism in Epithelial Ovarian Cancer Cells Via Activation of GLUT1 and HK2 Transcription.

FOXM1 promotes tumor cell invasion and correlates with poor prognosis in early-stage cervical cancer.

Overexpression of Forkhead Box Protein M1 (FOXM1) in Ovarian Cancer Correlates with Poor Patient Survival and Contributes to Paclitaxel Resistance

Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis

An extensive analysis of the prognostic and immune role of FOXO1 in various types of cancer

Critical Role of FOXO3a in Carcinogenesis

The Expression and Significance of FOXO3a and Jab1 in Human Ovarian Cancer